Completed PHASE4 INTERVENTIONAL 2-arm NCT00589628

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Sponsor: Childhood Arthritis and Rheumatology Research Alliance

Interventions infliximab

Updated 7 times since 2017 Last updated: Aug 22, 2013 Started: Sep 30, 2007 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00589628, this PHASE4 trial focuses on Chronic Uveitis and remains completed. Sponsored by Childhood Arthritis and Rheumatology Research Alliance, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Childhood Arthritis and Rheumatology Research Alliance
Egla C. Rabinovich

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States